Rising Biosciences (Rising Biosciences) Pretax Margin % : % (As of . 20)

View and export this data going back to . Start your Free Trial

What is Rising Biosciences Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Rising Biosciences's Pre-Tax Income for the three months ended in . 20 was $0.00 Mil. Rising Biosciences's Revenue for the three months ended in . 20 was $0.00 Mil. Therefore, Rising Biosciences's pretax margin for the quarter that ended in . 20 was %.

The historical rank and industry rank for Rising Biosciences's Pretax Margin % or its related term are showing as below:

RBII's Pretax Margin % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 4.06
* Ranked among companies with meaningful Pretax Margin % only.

Rising Biosciences Pretax Margin % Historical Data

The historical data trend for Rising Biosciences's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rising Biosciences Pretax Margin % Chart

Rising Biosciences Annual Data

Trend

Pretax Margin %

Rising Biosciences Quarterly Data

Pretax Margin %

Competitive Comparison of Rising Biosciences's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Rising Biosciences's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rising Biosciences's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rising Biosciences's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Rising Biosciences's Pretax Margin % falls into.

Rising Biosciences Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Rising Biosciences's Pretax Margin for the fiscal year that ended in . 20 is calculated as

Pretax Margin	=	Pre-Tax Income (A: . 20 )	/	Revenue (A: . 20 )
	=		/
	=	%

Rising Biosciences's Pretax Margin for the quarter that ended in . 20 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: . 20 )	/	Revenue (Q: . 20 )
	=		/
	=	%

Rising Biosciences (GREY:RBII) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Rising Biosciences Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Rising Biosciences's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Rising Biosciences (Rising Biosciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rising Biosciences Inc (GREY:RBII) » Definitions » Pretax Margin %

Traded in Other Exchanges

N/A

Address

1180 Cleveland Road, Sandusky, OH, USA, 44870

Website

http://www.risingbiosciences.com

Rising Biosciences Inc is a United States-based company engaged in research and development activities. It is focused on oral and topical cannabis and non-cannabis based pharmaceuticals. The company seeks to address the market demand for the treatment of the danger of opiates, whose long-term effects can include liver damage, addiction and brain damage due to hypoxia, resulting from respiratory depression, among other complications.